Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 859.4 INR -3.65% Market Closed
Market Cap: 153.9B INR

Intrinsic Value

The intrinsic value of one NATCOPHARM stock under the Base Case scenario is hidden INR. Compared to the current market price of 859.4 INR, Natco Pharma Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

NATCOPHARM Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Natco Pharma Ltd

Intrinsic Value History
Dive into the past to invest in the future

NATCOPHARM looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether NATCOPHARM usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about NATCOPHARM?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is NATCOPHARM valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Natco Pharma Ltd.

Explain Valuation
Compare NATCOPHARM to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about NATCOPHARM?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Natco Pharma Ltd

Current Assets 52.7B
Cash & Short-Term Investments 29.2B
Receivables 12.6B
Other Current Assets 11B
Non-Current Assets 33.6B
Long-Term Investments 3.4B
PP&E 26.6B
Intangibles 2.7B
Other Non-Current Assets 1B
Current Liabilities 9.4B
Accounts Payable 2.7B
Short-Term Debt 2.7B
Other Current Liabilities 4B
Non-Current Liabilities 803m
Long-Term Debt 46m
Other Non-Current Liabilities 757m
Efficiency

Free Cash Flow Analysis
Natco Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Natco Pharma Ltd

Revenue
44B INR
Cost of Revenue
-7.4B INR
Gross Profit
36.5B INR
Operating Expenses
-19.4B INR
Operating Income
17.1B INR
Other Expenses
-159m INR
Net Income
17B INR
Fundamental Scores

NATCOPHARM Profitability Score
Profitability Due Diligence

Natco Pharma Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Positive 3Y Average ROIC
Exceptional ROIC
Exceptional Operating Margin
hidden
Profitability
Score

Natco Pharma Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

NATCOPHARM Solvency Score
Solvency Due Diligence

Natco Pharma Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

Natco Pharma Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NATCOPHARM Price Targets Summary
Natco Pharma Ltd

Wall Street analysts forecast NATCOPHARM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NATCOPHARM is 938.4 INR with a low forecast of 719.12 INR and a high forecast of 1 260 INR.

Lowest
Price Target
719.12 INR
16% Downside
Average
Price Target
938.4 INR
9% Upside
Highest
Price Target
1 260 INR
47% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for NATCOPHARM is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

NATCOPHARM Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one NATCOPHARM stock?

The intrinsic value of one NATCOPHARM stock under the Base Case scenario is hidden INR.

Is NATCOPHARM stock undervalued or overvalued?

Compared to the current market price of 859.4 INR, Natco Pharma Ltd is hidden .

Back to Top